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Abstract
Palmitoyl Protein Thioesterase 1 (PPT1) is an essential lysosomal protein in the mammalian nervous system whereby defects
result in a fatal pediatric disease called Infantile Neuronal Ceroids Lipofuscinosis (INCL). Flies bearing mutations in the
Drosophila ortholog Ppt1 exhibit phenotypes similar to the human disease: accumulation of autofluorescence deposits and
shortened adult lifespan. Since INCL patients die as young children, early developmental neural defects due to the loss of
PPT1 are postulated but have yet to be elucidated. Here we show that Drosophila Ppt1 is required during embryonic neural
development. Ppt1 embryos display numerous neural defects ranging from abnormal cell fate specification in a number of
identified precursor lineages in the CNS, missing and disorganized neurons, faulty motoneuronal axon trajectory, and
discontinuous, misaligned, and incorrect midline crossings of the longitudinal axon bundles of the ventral nerve cord.
Defects in the PNS include a decreased number of sensory neurons, disorganized chordotonal neural clusters, and
abnormally shaped neurons with aberrant dendritic projections. These results indicate that Ppt1 is essential for proper
neuronal cell fates and organization; and to establish the local environment for proper axon guidance and fasciculation.
Ppt1 function is well conserved from humans to flies; thus the INCL pathologies may be due, in part, to the accumulation of
various embryonic neural defects similar to that of Drosophila. These findings may be relevant for understanding the
developmental origin of neural deficiencies in INCL.
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Introduction
Infantile Neuronal Ceroids Lipofuscinoses (INCL) belongs to a
group of lysosomal storage disorders characterized by the fatal
progressive deterioration of the visual and central nervous system,
and the accumulation of abnormal autofluorescent storage
materials in the brain [1,2]. INCL, the most severe form, results
from defects in the protein Palmitoyl Protein Thioesterase 1
(PPT1) which encodes a lysosomal thioesterase that cleaves long
fatty acids-most likely palmitate-attached to the cysteine residues
of S-acylated protein substrates [3,4]. In mammals, PPT1
expression is found in all cell types at varying quantities with the
highest levels in the brain, eye, and spleen [5,6]. In addition to
being found in lysosomal compartments of neurons, the protein is
also expressed in the pre-synaptic compartments [7,8,9].
Although ubiquitously expressed, PPT1 deficiency affects only
the development and maintenance of cortical neurons in the
nervous system. Afflicted children are normal at birth; but exhibit
progressive cognitive and motor deficits, seizures, and ocular
deterioration and eventual blindness by the age of 3; after which
INCL children remain in a vegetative state until death in their
teens. Microarray studies reveal that changes in gene expression
can be detected at 10 week-old post-natal PPT1 knock-out mice
brains, a time prior to neurodegenerative symptoms [10]. These
findings suggest that the loss of this protein may have embryonic
developmental consequences prior to being symptomatic. If PPT1
does have a role during embryonic neurogenesis, then the
elucidation of the fundamental cellular pathways requiring PPT1
during development will be critical.
Using Drosophila, we investigate the role of PPT1 during the
development of the embryonic nervous system. Previous studies
indicated that the removal of the Drosophila ortholog Ppt1 results in
phenotypes similar to human INCL [11,12]. Ppt1 loss-of-function
(LOF) flies lacking Ppt1 enzymatic activity display some aspects of
INCL disease: reduced life expectancy and an age-dependent
accumulation of autofluorescent storage material in the adult
CNS. Overexpression of Ppt1 in the larval visual system leads to
increased cell death [13]. A dominant gain-of-function modifier
screen for genes interacting with Ppt1 suggests that it has a role in
synaptic developmental pathways and the regulation of synaptic
vesicle endocytosis [14].
Here, we investigate the potential role of Ppt1 during the
generation of the nervous system by focusing on discreet identified
neuronal cell lineages. We hypothesize that while Ppt1 mutants
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the cellular level may be present in the form of altered cell fate
specification, proliferation, and axon guidance and connectivity.
Our results support this hypothesis and indicate that the loss of
Ppt1 has consequences much earlier than previously described.
Ppt1 defects lead to mis-specification of identified CNS and PNS
neural precursor cell fates, an abnormal complement of neural
precursors and neurons, and motoneuronal axonal misrouting and
overall defective axon pathfinding and fasciculation. These Ppt1-
associated embryonic phenotypes may contribute to the shortened
lifespan of Ppt1-deficient flies. These findings in Drosophila may be
relevant in identifying the earliest developmental neural defects in
INCL afflicted individuals and potential cellular targets for
therapeutic interventions.
Results
Drosophila Ppt1 RNA and protein are expressed at very
low/undetectable levels
To ascertain the endogenous RNA Ppt1 expression pattern
during development, whole mount in situ experiments on various
developmentally staged embryos (from 0 hr. to 16 hr), and wing,
leg, and eye imaginal discs using digoxygenin-labeled DNA and
RNA Ppt1 probes were performed. Both labeled probes reveal low
ubiquitous staining indicating that Ppt1 RNA is expressed
ubiquitously at a very low level (Figure S1 of Supporting
Information). These results support the hypothesis that Ppt1 acts
as a metabolic enzyme with housekeeping function with relatively
little need for high RNA concentration and/or turnover.
To examine localization of Ppt1 protein, four chicken/rabbit
polyclonal antibodies were generated against different regions of
Ppt1 that include both internal sequences and the C-terminus.
Embryonic, third-instar larvae, and whole adult male and female
lysates were used on Western blot to test all crude sera and affinity-
purified polyclonal antibodies. Results reveal that the endogenous
Ppt1 protein is undetectable under standard conditions (Figure
S2). To determine whether the Ppt1 polyclonal sera is specific to
Ppt1, Western blot using concentrated S2 Schneider cell lysates,
and adult fly head lysates (obtained via a collaboration with Dr.
Robert Glaser of Wadsworth Center of NYS Department of
Health) isolated from over-expressing UAS:Ppt1;P{GAL4-elav.L}
flies were performed. Results indicate that only when Ppt1 is over-
expressed at a high level (greater than 10 folds), or is highly
enriched in S2 lysates, can a band be detected at the expected size
of approximately 28 kD (Figure S2). Since Ppt1 has several
conserved glycosylation sites, de-glycosylation experiment using
PGNAse F (Invitrogen, Inc.) was carried out to confirm the
specificity of the Ppt1 polyclonal sera. Western blot reveals a single
band of ,28kD being shifted to a de-glycosylated band of 26 kD
which is similar in size as the mammalian PPT1 (Figure S2;
Verkruyse and Hoffmann, 1996). Since Ppt1 protein is only
detected when over-expressed on a Western, it indicates that (1)
the polyclonal antibodies were successful at detecting endogenous
Ppt1 protein; and (2) the protein is expressed at very low levels
endogeneously.
To investigate whether the loss of Ppt1 have consequences
during embryonic development, embryos homozygous for three
Ppt1 mutant strains were used: the Ppt1 null allele Df(1)446-20,
which removes Ppt1 and three neighboring genes [11]; and two
EMS-generated alleles: Ppt1
A179T which contains a point mutation
that changed alanine 179 to threonine; and Ppt1
S77F which
contains a point mutation that changed serine 77 to phenylalanine
[12]. Both EMS alleles exhibit no detectable Ppt1-specific enzyme
activity. Additionally, female embryos trans-heterozygous for
Df(1)446-20 and each point mutant alleles were generated in all
pair-wise combinations: Ppt1
A179T/Df(1)446-20, Ppt1
S77F/
Df(1)446-20, Ppt1
A179T/Ppt1
S77F. We compared neural develop-
ment of these embryos to those that are heterozygous for each
Ppt1 strains, namely Df(1)446-20/+, Ppt1
A179T/+, and Ppt1
S77F/+.
Ppt1-deficient embryos do not display autofluorescence
accumulation
INCL human patients and Ppt1 LOF flies exhibit accumulation
of autofluorescent deposits in adult brains due to the loss of protein
function. Previous studies indicated that adult Ppt1 mutant fly
brains exhibit larger, more abundant autofluorescent deposits than
wild type and this accumulation is visible several days after
pupation [12]. We also examined 14-day old wild type and Ppt1
LOF S77F adult fly brains for differences in autofluorescent
deposits. As in the previous studies, our results showed that there is
detectable difference in the levels of autofluorescent deposits.
Although wild type adult brains display minimal deposits, Ppt1
LOF brains had more deposits visible at various wavelengths. We
asked whether these accumulations are detectable during embryo-
genesis. Wild type and Ppt1 LOF stage 8–17 embryos were
examined for increased autofluorescent deposits in the developing
nervous system. We detected no difference in the level of
autofluorescence between wild type and Ppt1embryos at all stages
examined (data not shown) indicating that the accumulation of
abnormal storage materials is age-dependent and that the duration
of embryogenesis is not sufficient for build-up to occur.
Ppt1 mutants display aberrant cell fate specification in
early embryonic CNS development
We addressed the question of whether Ppt1 is involved in the
early events of neurogenesis- namely neural precursor specification
and division. We focused on the development of some of the most
well characterized neural cell lineages in the fly CNS using the
mAb EVE (mAb 2B8). EVE has a defined expression patterns in
ganglion mother cells (GMC) and daughter neurons of identified
neural precursor lineages NB1-1, 3-3, 4-2, and 7-1 [15,16,17,18].
EVE is expressed in the first-born precursor of NB1-1, GMC1-1a,
and its progeny, the aCC and pCC motoneurons; the EL neurons
deriving from NB3-3; GMC4-2 and its daughter neurons RP2
motoneuron and its sib from NB4-2, and the U/CQ neurons
deriving from NB7-1.
Results indicate that Ppt1 mutant embryos display abnormal
complement of EVE+ GMCs and their progeny in many
hemisegments, as early as stage 11/12 of embryogenesis. At stage
11–12, EVE is expressed in GMCs that produce the RP2
motoneuron and its sib; aCC/pCC and U/CQ neurons
(Figure 1A). Ppt1 mutant embryos from Df(1)446-20, Ppt1
A179T,
and Ppt1
S77F, and trans-heterozygous Ppt1 mutant crosses show a
variety of phenotypes. Some embryos display cellular disorgani-
zation where EVE+ GMCs are displaced. In others, there is a loss
or gain of extra EVE-positive GMCs and neurons in many
hemisegments (Figure 1B–E). The most prevalent phenotype is the
loss of GMC4-2.a, the parental precursor that will give rise to the
RP2 motoneuron. Occasionally, extra U/CQ and aCC/pCC
GMCs are also observed as also the presence of extra RP2s or its
sib after GMC4-2.a has divided (Figure 1D–E). Overall, 31%
(n=42) of Ppt1- embryos display abnormality at stage 12. Later in
embryonic development during stage 14–15 when the EVE+
GMCs give rise to EVE+ neurons, the loss of EVE+ RP2s is
observed in a small, but significant percentage of hemisegments in
Ppt1mutants (Figure 2; Table 1). Specifically, over 36% of T1-A8
hemisegments show a loss of RP2s in Df(1)446-20 embryos. Point
Ppt1is Needed in Neurogenesis
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hemisegments (Table 1). The degree of penetrance of this EVE
neural phenotype is variable: all Df(1)446-20 embryos show at
least two missing RP2s whereas Ppt1
A179T and Ppt1
S77F point
mutations range from 32–50%. 63% of embryos from
Ppt1
A179T6Df(1)446-20 trans-heterozygous crosses and 27% of
Ppt1
S77F6Df(1)446-20 trans-heterozygous crosses display a partial
loss of EVE+ RP2 neurons (Figure 2; Table 2). In contrast, all Ppt1
mutant strains outcrossed to wild type Oregon-R, Df(1)446-20/+,
Ppt1
A179T/+, and Ppt1
S77F/+, all showed normal EVE expression
(Tables 1 and 2). These results indicate that the EVE phenotypes
are due to the loss of Ppt1.
Figure 1. Ppt1 LOF mutants exhibit abnormal complement of EVE+ neural precursors and neurons. (A) In wild type, EVE is expressed in
GMC4-2.a, the neural precursor that give rise to RP2 motoneuron and its sib (arrow); and in a cluster of GMCs that give rise to the aCC, pCC, CQ
neurons (arrowhead). (B–E) In Ppt1 mutants, many hemisegments exhibit a variety of phenotype including the loss of GMC4.2a (arrow in B and E),
extra RP2/sib neurons (arrowhead in D), disorganized EVE+ clusters (C), and extra aCC/pCC cells (arrowhead in E). In all panels, embryos are at S11–12
of development; anterior, up; caret, midline.
doi:10.1371/journal.pone.0014402.g001
Figure 2. Loss of Ppt1 results in missing EVE+ RP2 neurons in many hemisegments of S16 embryonic CNS. Arrowhead indicates RP2
neuron in all panels. (A). Wild type EVE+ CNS pattern. (B–E) Ppt1 LOF mutants exhibit a variety of phenotype including the loss of EVE+ RP2s in some
hemisegments (red arrowhead in B–E), disorganized or missing aCC/pCC clusters (white arrowhead in B, D and E). Anterior, up; caret, midline.
doi:10.1371/journal.pone.0014402.g002
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innervation of the RP2 motoneuron [19] thus EVE can provide
clues as to whether the observed alterations in cell fate lead to
faulty axon pathfinding and innervation. To verify the mis-
specification of neuronal cell fates in the EVE+ lineages as well as
to assess the RP2 axonal projections, Df(1)446-20 and Ppt1
A179T
flies were crossed to lines bearing either the UAS-tau-LacZ or UAS-
CD8-GFP reporter (RN2-Gal4:UAS-CD8-GFP or RN2-GAL4:UAS-
tau-LacZ) driven by the RP2/aCC/pCC-specific Gal4 driver (RN2-
Gal4) to clearly mark the cell bodies and axons of aCC and pCC,
and RP2 neurons [20]. Anti- b-gal staining and GFP visualization
of embryos from these crosses confirmed EVE staining results.
Ppt1;RN2-Gal4:UAS-CD8-GFP and Ppt1; RN2-Gal4:UAS-tauLacZ
embryos display a loss of either tauLacZ or GFP-expressing
RP2s and aCC/pCC neurons in many hemisegments; and
disorganized cellular arrangements of the remaining LacZ-positive
neurons. In many Ppt1 mutants, the remaining RP2 motoneuron
exhibits abnormal axon trajectory (Figure 3). Normally at late
embryogenesis, the RP2 motoneuron extends its axon anteriorly
toward the ipsilateral neighboring anterior segment to join the
intersegmental nerve (ISN) to exit the CNS and eventually
synapsing onto the dorsal muscle (Figure 3A). In many Ppt1
A179T;
UAS-tauLacZ embryos, the RP2 neurons extend its axons in the
wrong direction-posteriorly to join the posterior ipsilateral ISN
instead (Figure 3D) while other RP2 axons project contralaterally
toward the midline, stalled, and never exit the CNS (Figure 3E).
These embryos also display a loss of either aCC or pCC neurons
in many hemisegments (Figure 3B–E). Collectively, these studies
indicated that the loss of Ppt1 caused abnormal neuronal cell fate
specification and defective axon pathfinding.
Embryonic glial development is normal in Ppt1 mutants
Since neuronal and glial development are temporally and
spatially linked and can be derived from a common neuronal
precursor (e.g. NB1-1 produces both aCC/pCC neurons as well as
the A and B glia located dorsally on the CNS [21] ), glial
development was examined using the glial-specific marker REPO
(mAb 8D12). The evolutionary conserved REPO protein is
expressed in most glia in the embryonic CNS and PNS. During
embryogenesis, REPO is essential for the migration and
differentiation of glia, particularly the longitudinal glia of the
CNS and the exit glia of the PNS. All Ppt1 LOF mutants exhibit
normal REPO-positive glia; thus Ppt1 is not essential for the
specification of embryonic glia (data not shown).
Ppt1 mutants exhibit variable embryonic CNS and PNS
axonal defects
Overall axon guidance and fasciculation during neural
development were examined using a number of axonal markers,
BP102, FUTSCH (mAb22C10), and Fasciclin II (mAb1D4). In
wild type, the axon tracts of the embryonic CNS consist of two
longitudinal axon bundles running lengthwise along the ventral
nerve cord intersected by segmentally reiterated pairs of anterior
and posterior commissures that crosses the midline at every
segment (Figure 4A). The CNS axon scaffold can be visualized
using BP102 which recognizes a carbohydrate epitope present on
all CNS axons [22]. 73% of Df(1)446-20, 35% of Ppt1
A179T, and
24% of Ppt1
S77F embryos show mild to severe defects (Figure 4;
Table 3). Mild defects include irregularly spacing of the ventral
nerve cord, some disorganization of the axon scaffold, abnormally
thin or thick, and wavy longitudinal connectives. Moderate defects
include narrowing of spaces between the commissures (Figure 4B),
broader and/or more compressed anterior and posterior commis-
sures, and interrupted, frayed longitudinal connectives (Figure 4C).
Severe defects observed include severe disorganization of the
longitudinal tracts at many segments, the complete loss of
longitudinal connectives in other segments, and fused or missing
commissures (Figure 4C & D).
To evaluate the morphology of a more discrete subset of axonal
longitudinal connectives, Df(1)446-20, Ppt1
A179T, and Ppt1
S77F, and
trans-heterozygous Ppt1 mutant embryos were stained with
mAb1D4. At stage 17, mAb1D4 recognizes the neural adhesion
protein Fasciclin II, which is expressed in three discrete axon
longitudinal bundles on either side of the midline (Figure 5A; [23]).
50–58% of Ppt1 mutant embryos display abnormal FasII-positive
longitudinal connectives ranging from mild to severe (Table 3).
Mild defects include loose and defasciculated connectives, wavy in
appearance. More severe FasII defects include ectopic midline
crossing of the longitudinal connectives, discontinuous connectives
in all three FasII bundles, and frayed connectives due to
defasciculation (Figure 5B).
We examine the specific requirement of Ppt1 in neurons by
driving the expression of Ppt1-RNAi in strains containing the ds
RNA-GD3286 construct (obtained from the Vienna Drosophila
RNAi Center [24]); and the dsRNA-JF01972 construct from the
TriP-1 collection (Bloomington Drosophila Stock Center) using
various neural-specific Gal4 drivers (Bloomington Drosophila
Table 1. Percentage of hemisegments in Ppt1-deficient
embryos with missing EVE+ RP2 neurons.
genotype % n
wild type 0 220
Ppt1
Df(1)446-20 36.4 220
Ppt1
Df(1)446-20/+ 02 2 0
Ppt1
A179T 16 198
Ppt1
A179T/+ 02 2 0
Ppt1
S77F 17 198
Ppt1
S77F/+ 02 2 0
Ppt1
S77F/Ppt1
Df(1)446-20 12 220
Ppt1
A179T/Ppt1
Df(1)446-20 12 374
n, number of hemisegments at stage 14–16.
doi:10.1371/journal.pone.0014402.t001
Table 2. Penetrance of EVE+ RP2 phenotype in Ppt1-
embryos.
genotype % n
wild type 0 30
Ppt1
Df(1)446-20 100 25
Ppt1
Df(1)446-20/+ 01 0
Ppt1
A179T 50 18
Ppt1
A179T/+ 01 0
Ppt1
S77F 32 28
Ppt1
S77F/+ 01 0
Ppt1
S77F/Ppt1
Df(1)446-20 27 37
Ppt1
A179T/Ppt1
Df(1)446-20 63 24
%, percentage of stage 15–16 embryos with 2 or more missing RP2s.
n, number of embryos scored.
doi:10.1371/journal.pone.0014402.t002
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nucleotides within the first exon of the Ppt1 gene; the dsRNA-
JF01972 construct recognizes 531 nucleotides-nearly all the first
exon of the gene. Ppt1-RNAi embryos were examined for Ppt1-
associated FasII defects. 85–100% Ppt1RNAi-elav-Gal4 embryos
display defects ranging from mild to severe axon bundles
(Figure 5C and D; Table 4). Similarly, 85% of Ppt1RNAi- U/
CQ-Gal4 and 93% Ppt1RNAi-aCC/RP2-Gal4 embryos exhibit
varying degrees of axon defects ranging from wavy but intact
bundles; to frayed, discontinuous or missing bundles in many
hemisegments. In contrast, embryos from the parental strains
exhibit normal axon patterns (Table 5). These results collectively
indicate that Ppt1 is essential in the neurons for proper axon
guidance and fasciculation.
The developing PNS of Ppt1 mutants also show neuronal defects
as assayed by 22C10, an antibody that recognizes the cytoskeletal
FUTSCH protein found in the cytoplasm of a subset of CNS and
PNS neurons and axons as well as their projections [25].
Normally, FUTSCH is expressed in the cell bodies as well as
the axons and dendrites of 44 PNS neurons per abdominal
segment [26]. 22C10-positive PNS neurons include the dorsal
cluster (d), the ventral and ventral’ cluster (v and v9), and the
lateral cluster which consists of five chordotonal organs (lch5).
Wild type and Ppt1 LOF embryos showed no detectable difference
in the number of neurons or axon projections in the l, v, and v9
neuron clusters. However, the lch5 neurons showed a variety of
defects including decreased number of sensory neurons, fused and
abnormally shaped neurons, and disorganized clusters with
aberrant dendritic projections (Figure 6; Table 5). Occasionally,
fasciculation defects with abnormal axonal connections between v9
clusters and ISN are observed (data not shown). These findings
indicate that lch5 neuron clusters are preferentially more sensitive
than l, v, and v9 clusters to the loss of Ppt1.
Discussion
RNA and antibody expression results reveal the low abundance
nature of Ppt1 RNA and protein confirming what was previous
thought- Ppt1 is an essential housekeeping gene. Because of its low
abundance, we are unable to ascertain the subcellular localization
of Ppt1 and thus could not determine whether fly Ppt1 is
lysosomal, synaptic, or both. To address this question, Ppt1 would
need to be over-expressed by at least 17-folds to be at a marginally
detectable level using immunofluorescence. This is not ideal since
Ppt1 over-expression leads to apoptosis. Our studies clearly
indicate that Ppt1 protein is expressed ubiquitously at a very low
level such that only a minute amount is required for function.
Whether this minute amount of protein resides predominantly in
Figure 3. Ppt1 mutants exhibit abnormal RP2 axon trajectories. S16 ventral nerve cord stained with anti-b-gal to detect RN2-tau-lacZ
expressed in aCC, pCC and RP2 neurons. (A) Wild type RN2-tau-lacZ pattern showing RP2 neuron and its axon trajectory (white arrow); and aCC/pCC
neurons (arrowhead). (B–D). Ppt1
A179T; RN2-Gal4:UAS-tauLacZ embryos display a loss of RP2 motoneurons (asterisks) and aCC/pCC neurons
(arrowheads) in many hemisegments; and disorganized cellular arrangements of the remaining LacZ-positive neurons. Many hemisegments have
normal RP2 axon trajectory (white arrow) while others do not (black arrow). The RP2 in panel C shows an abnormal axon trajectory projecting
posteriorly instead of anteriorly. Panel E is an enlarged subset of B. Anterior, up; caret, midline.
doi:10.1371/journal.pone.0014402.g003
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developmental proteins, it is necessary and its absence would most
likely have similar consequences.
Our results indicate that Ppt1 is essential at a time when neural
precursors are being determined, one of the earliest stages of
embryonic neural development. Small discreet defects were
detected early shortly after gastrulation with the alteration in
CNS neural precursor cell fates in a number of identified neural
precursors. Specifically, the phenotype is limited to a discreet
subset of EVE+ neural lineages (e.g. the neuroblast lineage giving
rise to RP2s, aCC and pCC neurons); while other EVE+ cells such
as U’s and EL interneurons are normal. In the affected lineages,
the loss of Ppt1 has small consequences at the early cell
determination stage such that only a subset of all EVE+ RP2s,
aCC/pCC neurons are affected. This indicates that even at this
very early stage of neurogenesis, Ppt1-mediated protein turnover is
essential. Neural defects increase as development proceeds such
that by mid-to–late embryogenesis, malformed neurons and
abnormal longitudinal axon tracts are visible in nearly all Ppt1-
deficient embryos. Specifically, the development of the RP2, aCC
and pCC neurons requires Ppt1; most likely through regulating
EVE expression. Without Ppt1, many RP2, aCC/pCC neurons
are abnormally positioned or missing; while some exhibit aberrant
axon projections. Since EVE regulates proper axon projections in
the developing CNS, particularly dorsally projecting aCC and
RP2 motoneurons (pCC is an interneuron), this phenotype is
wholly unexpected. These pathfinding and fasciculation defects
reflect what we suspect: Ppt1-mediated turnover of palmitoylated
developmental proteins is necessary throughout development such
that its loss is cumulative and progressive. This is supported by
previous studies showing that young adult brains exhibit age-
dependent abnormal autofluorescence deposits due to the absence
of Ppt1 [12]. Neurons, in particular, exhibit a high rate of
palmitoylation-depalmitoylation dynamics due to its high level of
signal transduction and protein trafficking through neurotrans-
mitter release. Since there are numerous endosomal/lysosomal
pathways, the loss of one protein would not necessarily result in
massive disturbances but may limit the number of protein
turnovers and recycling which may cause a ‘‘domino’’ effect by
directly or indirectly disrupting downstream pathways during
neural development.
Downstream targets of Ppt1 during neurogenesis are largely
unknown. A previous study indicates that FasII, a neural
adhesion protein, may be a candidate [14]. Ppt1 over-expression
screens have isolated FasII as a potential Ppt1-interacting protein.
Our results showed that Ppt1-deficient embryos display FasII-
specific axon fasciculation defects. FasII, a homolog of the
vertebrate NCAM, is a palmitoylated protein and serves as a
second anchor for proteins involved in N-CAM mediated
signaling at the membrane [27]. Fasll has also been shown to
interact with lipid rafts to mediate FGF signaling to promote
neurite outgrowth [28]. Perhaps Fasll plays a similar role during
Table 3. Percentage of Ppt1-deficient embryos displaying
axonal defects.
Antibody staining Wild type Df(1)446-20 Ppt1
A179T Ppt1
S77F
anti-BP102 0% (6) 73% (34) 35% (34) 12% (49)
anti-fasII (1D4) 0% (11) 58% (36) 50% (46) n/d
Anti-FUTSCH (22C10) 0% (10) 70% (50) 60.5% (38) n/d
Parentheses, the number of stage 16–17 embryos assayed.
n/d: not determined.
doi:10.1371/journal.pone.0014402.t003
Figure 4. CNS scaffold abnormalities in Ppt1 mutant embryos. In all panels, S16 embryos were stained with BP102. (A) Wild type embryo. (B)
Axon defects range from mild phenotypes such as irregularly spaced axon tracts in commissures and wavy, thinning longitudinal connectives; to
more severe phenotype such as fused commissures and disorganized CNS tracts (C and D). Anterior, up.
doi:10.1371/journal.pone.0014402.g004
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signaling. Since Ppt1 has been suggested to also facilitate cell
signaling via its localization to lipid rafts [29], FasII may require
Ppt1-mediated palmitoylation turnover at the membrane to
regulate the integration of signaling required to insure proper
axon outgrowth and fasciculation.
The loss of Ppt1 has varied consequences from the loss or gain of
neurons, axon fasciculation defects, to axon guidance in a subset of
motor neurons (e.g. RP2, aCC), sensory neurons, and interneurons
(e.g. pCC but not the EL interneurons). This observation is
analogous to what is observed in INCL humans and animal
models. INCL patients undergo progressive degeneration in
selective areas of the brain while leaving others intact. PPT1-
deficient adult mice exhibit the loss of GABAergic interneurons in
discrete regions of the brain [10] and thalamic neurons [30]
months prior to being symptomatic. It is presently unclear whether
PPT1-deficiencies affect mice earlier, during embryonic neural
development.
The low penetrance of Ppt1 phenotype indicates that the loss of
Ppt1 is generally well tolerated perhaps due to the presence of
compensatory mechanisms. A closely related sister gene, PPT2,
exists in mammals [31] and in Drosophila. PPT2 knock-out mice
display many of the same INCL phenotype and pathology
including spasticity and autofluorescence accumulation in the
brain [32]. We are currently investigating whether the PPT2 fly
homolog, Ppt2, also have an embryonic neural phenotype and
whether Ppt1/Ppt2 double mutants have a more severe phenotype
than the single mutation.
Materials and Methods
Drosophila Strains
Ppt1 LOF mutant alleles Ppt1
A179T, Ppt1
S77F, and the Df(1)446-
20 deficiency line were provided by Dr. Robert Glaser (Wads-
worth Center, NYS Department of Health, Albany, NY). Oregon-
R, w
*; P{RN2-GAL4}P, P{UAS-tau-lacZ.B}2 and w
*; P{RN2-
GAL4}P, P{UAS-mCD8::GFP.L}LL5 , Elav-Gal4 driver, U/CQ-
Gal4 driver, aCC/RP2-Gal4 driver, and Ppt1-RNAi TRiP line,
and Oregon-R were obtained from Bloomington Drosophila Stock
Center. Ppt1- UAS RNAi flies (w1118; P{GD3286} [14]) was
obtained from Vienna Drosophila RNAi Center (Vienna, Austria).
All strains were maintained on standard Drosophila cornmeal-yeast
medium at 25uC.
To detect autofluorescence deposits, brains from 14-day old
Oregon-R and Ppt1
S77F were extracted and immediately examined
on a Leica SP2 confocal microscope for comparison.
Figure 5. Mutant Ppt1 and Ppt1 RNAi knock-down in neurons result in defective axon tracts in the developing CNS. In all panels, S17
embryos were stained with 1D4 antibody. (A) FASII is expressed in three longitudinal connectives at this stage. (B) Ppt1
A179T embryos exhibit
discontinuous and frayed longitudinal connectives. (C, D) Ppt1 RNAi expression under the control of elav gal4 driver results in a range of axon
guidance phenotype including wavy bundles with some faulty axon crossing over the midline (arrow in C); and disorganized and/or broken
connectives, and fused commissures (arrows in D). Anterior, up.
doi:10.1371/journal.pone.0014402.g005
Table 4. Quantitation of Ppt1 RNAi embryos displaying FasII
defects.
genotype % defective
Ppt1
5499RNAi 0.03 (30)
Ppt1
25952TRiP RNAi 0 (30)
elav-gal4 0 (33)
UAS tauLacZ CQ2-gal4 0 (30)
UAS tauLacZ RN2-gal4 0 (35)
Ppt1
5499RNAi6elav-gal4 100 (81)
Ppt1
25952TRiP RNAi6elav-gal4 85.7 (42)
Ppt1
5499RNAi6UAS tauLacZ CQ2-gal4 85 (67)
Ppt1
5499RNAi6UAS tauLacZ RN2-gal4 93.4 (106)
Parentheses, the number of stage 16–17 embryos assayed.
Ppt1 RNAi expression is driven by the following neural specific Gal4 drivers:
elav-gal4-drives expression in CNS and PNS neurons.
UAS tau-LacZ CQ2-gal 4 driver- drives tau-LacZ expression in U/CQ neurons.
UAS tau-LacZ RN2-gal 4 driver- drives tau-LacZ expression in aCC and RP2
neurons.
doi:10.1371/journal.pone.0014402.t004
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phenotype Wild type Ppt1
A179T Ppt1
446-20
Ppt1
5499RNAi6
elav-gal4
Ppt1
25952TRiP
RNAi6elav-gal4
Ppt1
5499RNAi6UAS
tauLacZ CQ2-gal4
Ppt1
5499RNAi6UAS
tauLacZ RN2-gal4
PNS
Irregular spacing of
lch5 neuron clusters
0 6 6 n/d n/d n/d n/d
Missing lch5 neurons 0 4 6 n/d n/d n/d n/d
Malformed lch5
neurons
0 13 13 n/d n/d n/d n/d
CNS
slightly irregular and/
or wavy longitudinal
tracts
0 31 21 40 9 25 7
Discontinuous, frayed
longitudinal tracts
0 8 11 35 33 35 99
Irregular, missing or
fused commissures
01 61 7 6 1 4 7 1 0
Total number of
embryos scored
27 69 58 81 42 67 106
-number of embryos of each genotype displaying various fasII and 22C10 defects; many embryos exhibit combination of phenotypes.
n/d: not determined.
doi:10.1371/journal.pone.0014402.t005
Figure 6. Chordotonal neurons (lch5) in the developing PNS are abnormal in many Ppt1 LOF embryos. In all panels, lch5 neurons are
indicated by the arrows. Side view of S17 embryos stained with Mab 22C10. (A) Wild type clusters of lch5, v, and v9 neurons are located in every
abdominal segment. (B–E) lch5 neurons in mutant Ppt1 embryos demonstrate a variety of defects: decreased number of neurons (B), fused and
abnormally shaped (D, E), organization and positional defects, and thin axon bundles (black arrowhead) (B and C). dorsal, up.
doi:10.1371/journal.pone.0014402.g006
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Embryos were fixed and stained according to previously
described methods [33,34], and using the following primary
antibodies obtained from University of Iowa Developmental
Studies Hybridoma Bank: mAb 22C10 (1:50), mAb BP102
(1:50), mAb 2B8 (1:30), and mAb 1D4 (1:5). b-gal monoclonal
antibody at 1:1000 obtained from Jackson ImmunoResearch, Inc.
Immunocytochemical detection was performed using HRP-
conjugated goat anti-mouse secondary antibody (1:300; Jackson
ImmunoResearch, Inc.). Immunofluorescence was performed
using Alexa-488 and Alexa-594 conjugated goat anti-mouse
secondary antibodies (1:300; Molecular Probes/ Invitrogen,
Inc.). For each genotypic staining of EVE, 100–200 thoracic and
abdominal hemisegments from at least 20 appropriately staged
embryos were counted. Digital images of stained embryos were
captured using either the Advanced Color SPOT system or the
Retiga EXi Fast 1394 mounted onto a Nikon E600 compound
microscope.
Supporting Information
Figure S1 Whole mount in situ RNA hybridization reveals that
Ppt1 transcript is ubiquituously expressed at low levels during (A)
embryogenesis and (B) 3rd instar imaginal discs. 0–16 hours wild
type embryos and 3rd instar imaginal discs were collected, fixed
and hybridized with digoxygenin-labeled anti-sense Ppt1 RNA
probes. Anti-sense RNA probes were generated from a CG12108
cDNA clone GM21019 (Research Genetics). Embryo in situ
hybridization was performed using standard protocols.
Found at: doi:10.1371/journal.pone.0014402.s001 (0.82 MB
PDF)
Figure S2 Western blot using affinity-purified Ppt1 polyclonal
antibody (generated against the C-terminus) of S2 cell lysate, wild
type W1118 fly head extract (arrows), and over-expressed Gal4-
UAS-Ppt1 head extract untreated (A) and treated with pGNAse
(B) to remove N-glycosylation. Results indicate that although no
band is detected in the S2 lysate and W1118 lanes (arrows), Ppt1
antibody is specific to Ppt1 protein and can be detected when Ppt1
is over-expressed (A and B). Two rabbit and two chicken
polyclonal antibodies were generated using the following peptides
located in the internal region of the Ppt1 gene: VAERCP-
NPPMRNLIT, ATYWHDPIMENKYR, and IVQPKESQWF-
QYYTT ; and VYQNLGLDKMHRQGQ located at the C-
terminal region (GeneMed Synthesis, Inc.; Aves Laboratories,
Inc.). Affinity purifications were performed using the Pierce
Biotechnology SulfoLink (#20405) and AminoLink kit (#44890)
according manufacturer’s standard protocols. Western blot was
performed using the ECL Western Blotting Analysis System
(Pierce Biotechnology). Deglycosylation experiments were per-
formed using lysates prepared from S2 Schneider cells, and adult
fly heads from W1118 and UAS:Ppt1 2.1/GMR:GAL4 flies.
Samples were treated with PGNase F according to manufacturer’s
instruction (glycerol free kit #P0705S; New England Biolabs, Inc.)
prior to Western Blotting.
Found at: doi:10.1371/journal.pone.0014402.s002 (0.29 MB
PDF)
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